Timing of Endoscopy in Cirrhotic Patients with Acute Variceal Bleeding (NCT06031402) | Clinical Trial Compass
RecruitingNot Applicable
Timing of Endoscopy in Cirrhotic Patients with Acute Variceal Bleeding
China368 participantsStarted 2024-09-04
Plain-language summary
Endoscopy is important for the diagnosis and treatment of acute upper gastrointestinal bleeding (AUGIB), especially acute variceal bleeding (AVB), in patients with liver cirrhosis. However, the optimal timing of endoscopy remains controversial, primarily because the currently available evidence is of poor quality, and the definition of early endoscopy is also very heterogeneous among studies. Herein, a multicenter randomized controlled trial (RCT) is performed to explore the impact of timing of endoscopy on the outcomes of cirrhotic patients with AVB.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. patients with AUGIB which is highly suspected to be caused by gastroesophageal variceal rupture;
✓. patients with a diagnosis of liver cirrhosis based on imaging and pathology;
✓. patients and/or their relatives who sign informed consents;
✓. patients' age ≥18 years.
Exclusion criteria
✕. patients who have undergone endoscopy at other hospitals before admissions;
✕. patients' hemodynamics are unstable after resuscitation;
✕. patients with severe cardiovascular or cerebrovascular diseases or renal injury;
✕. patients who have taken anticoagulants or antiplatelet drugs within 2 weeks before admissions, or are diagnosed with severe hematological diseases;
✕. patients with human immunodeficiency virus or other acquired or congenital immune deficiency diseases;
✕
What they're measuring
1
The failure to control bleeding after admissions
Timeframe: within 5 days admission
2
6-week rebleeding
Timeframe: 6-week
Trial details
NCT IDNCT06031402
SponsorGeneral Hospital of Shenyang Military Region